Frequency and Outcomes of Early Onset Seizures after Ischemic Stroke
Journal Title: Journal of Neurology and Experimental Neuroscience - Year 2015, Vol 1, Issue 2
Abstract
Introduction: Stroke is most common cause of new onset seizures in elderly. In this study, we assessed frequency and outcome by National Institute of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) in early onset seizures after ischemic stroke. Methods: Case records of all patients during period of June 2013-June 2014 from indigenously made stroke registry of Narayana medical college & Hospital were reviewed. Only cases with early onset of seizures (< 14 days) after ischemic stroke were included as cases (14/304), remaining ischemic stroke patients without seizures are enrolled as controls (290/304). We recorded morbidity, mortality, length of hospital stay, NIHSS and mRS scores from the available data. Results: A total of 304 case records of stroke patients were analysed. Mean age of patients was 53.62 ± 13.06 years (20-85). Frequency of early onset seizures seen in 14 (4.6%) patients. Types of seizures observed in these patients are Generalised tonic clonic seizuresw-6, Focal seizures-5, Epilepsia Partialis Continua-2 and Complex Partial Seizures-1. 12 patients had cortical infarcts while remaining 2 had sub cortical infarcts. Phenytoin and Oxcarbamazepine were preferred drugs even though more than 50% had partial seizures in one or other form. During the follow up, recurrent seizure or mortality was not observed. No statistically significant difference in duration of hospital stay, NIHSS and mRS score at admission and at discharge between patients with and without seizures. Conclusion: Even though we followed for a short period of one year we observed a sizeable proportion (4.6% of 304) of ischemic stroke cases with early onset seizures. On other hand, stroke severity has no influence on seizures or seizures have no influence on functional outcome.
Authors and Affiliations
Sai Sampath Kumar Natuva, Bala Khaseem D, Ravi Kiran Padala, Sunanda T, Ganesh Vallampalli
Keywords
Related Articles
- EP ID EP223783
- DOI 10.17756/jnen.2016-007
- Views 141
- Downloads 0
Stroke Survivors: Needs, Wellness and Warning Signs in a Stroke Support Group Population
Aim: This study was designed to investigate needs of stroke survivors in stroke support groups, including their knowledge of warning signs, and the effectiveness of their care provider in acquiring rehabilitation service...
GSK249320, A Monoclonal Antibody Against the Axon Outgrowth Inhibition Molecule Myelin-Associated Glycoprotein, Improves Outcome of Rodents with Experimental Stroke
Myelin-associated glycoprotein (MAG) is an inhibitor of axon growth. MAG levels increase after stroke. GSK249320 is a monoclonal antibody that neutralizes MAG-mediated inhibition and so may promote axon outgrowth and imp...
Vanillin a Food Additive Ameliorates Harmaline Induced Tremor in Rats
Background: Essential tremor (ET) is a common neurological disorder. Genetic, environmental and dietary factors have been suggested to contribute to ET. The present study investigates the effect of vanillin, a polyphenol...
Resolution of Chronic Headache Following Pineal Cyst Fenestration. Case Report
Objective: We report a single case of resolution of chronic incapacitating headache following surgical fenestration of a large pineal cyst. Background: There is an established link between pineal cysts and headaches part...
Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to its receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface. Recent studies indicate that neurons bu...